Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Mar 21, 2021; 27(11): 1101-1116
Published online Mar 21, 2021. doi: 10.3748/wjg.v27.i11.1101
Figure 3
Figure 3 Cumulative incidence of hepatocellular carcinoma. A: Incidence of hepatocellular carcinoma after hepatitis B e antigen negative conversion in hepatitis B e antigen-positive chronic hepatitis B patients; B: Cumulative incidence of hepatocellular carcinoma after hepatitis B virus-DNA negative conversion in patients with chronic hepatitis B. HCC: Hepatocellular carcinoma; HBeAg: Hepatitis B e antigen; HBV: Hepatitis B virus.